The global market for Lisdexamfetamine Dimesylate Capsules was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Lisdexamfetamine dimesylate capsules are a prescription medication primarily used to treat attention deficit hyperactivity disorder (ADHD) and, in some cases, moderate to severe binge eating disorder.

North American market for Lisdexamfetamine Dimesylate Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Lisdexamfetamine Dimesylate Capsules is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Lisdexamfetamine Dimesylate Capsules include Takeda Pharmaceutical, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Sun Pharmaceutical, Teva Pharmaceutical, Mallinckrodt PLC, Mylan, Sandoz, Ascent Pharmaceuticals, Alkem Laboratories, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lisdexamfetamine Dimesylate Capsules, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lisdexamfetamine Dimesylate Capsules.

The Lisdexamfetamine Dimesylate Capsules market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lisdexamfetamine Dimesylate Capsules market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Lisdexamfetamine Dimesylate Capsules manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lisdexamfetamine Dimesylate Capsules Market Report

Report Metric	Details
Report Name	Lisdexamfetamine Dimesylate Capsules Market
Segment by Type	10mg per Unit 20mg per Unit 30mg per Unit 40mg per Unit 50mg per Unit 60mg per Unit 70mg per Unit
Segment by Application	Attention Deficit Hyperactivity Disorder(ADHD) Bulimia Other
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Takeda Pharmaceutical, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Sun Pharmaceutical, Teva Pharmaceutical, Mallinckrodt PLC, Mylan, Sandoz, Ascent Pharmaceuticals, Alkem Laboratories, Apotex, Lannett, Zhejiang Huahai Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Lisdexamfetamine Dimesylate Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Lisdexamfetamine Dimesylate Capsules in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Lisdexamfetamine Dimesylate Capsules Market report?

Ans: The main players in the Lisdexamfetamine Dimesylate Capsules Market are Takeda Pharmaceutical, Hikma Pharmaceuticals, Amneal Pharmaceuticals, Sun Pharmaceutical, Teva Pharmaceutical, Mallinckrodt PLC, Mylan, Sandoz, Ascent Pharmaceuticals, Alkem Laboratories, Apotex, Lannett, Zhejiang Huahai Pharmaceutical

What are the Application segmentation covered in the Lisdexamfetamine Dimesylate Capsules Market report?

Ans: The Applications covered in the Lisdexamfetamine Dimesylate Capsules Market report are Attention Deficit Hyperactivity Disorder(ADHD), Bulimia, Other

What are the Type segmentation covered in the Lisdexamfetamine Dimesylate Capsules Market report?

Ans: The Types covered in the Lisdexamfetamine Dimesylate Capsules Market report are 10mg per Unit, 20mg per Unit, 30mg per Unit, 40mg per Unit, 50mg per Unit, 60mg per Unit, 70mg per Unit

1 Lisdexamfetamine Dimesylate Capsules Market Overview

1.1 Product Definition

1.2 Lisdexamfetamine Dimesylate Capsules by Type

1.2.1 Global Lisdexamfetamine Dimesylate Capsules Market Value Comparison by Type (2024 VS 2031)

1.2.2 10mg per Unit

1.2.3 20mg per Unit

1.2.4 30mg per Unit

1.2.5 40mg per Unit

1.2.6 50mg per Unit

1.2.7 60mg per Unit

1.2.8 70mg per Unit

1.3 Lisdexamfetamine Dimesylate Capsules by Application

1.3.1 Global Lisdexamfetamine Dimesylate Capsules Market Value by Application (2024 VS 2031)

1.3.2 Attention Deficit Hyperactivity Disorder(ADHD)

1.3.3 Bulimia

1.3.4 Other

1.4 Global Lisdexamfetamine Dimesylate Capsules Market Size Estimates and Forecasts

1.4.1 Global Lisdexamfetamine Dimesylate Capsules Revenue 2020-2031

1.4.2 Global Lisdexamfetamine Dimesylate Capsules Sales 2020-2031

1.4.3 Global Lisdexamfetamine Dimesylate Capsules Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Lisdexamfetamine Dimesylate Capsules Market Competition by Manufacturers

2.1 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Manufacturers (2020-2025)

2.2 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Lisdexamfetamine Dimesylate Capsules Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Lisdexamfetamine Dimesylate Capsules, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Lisdexamfetamine Dimesylate Capsules, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Lisdexamfetamine Dimesylate Capsules, Product Type & Application

2.7 Global Key Manufacturers of Lisdexamfetamine Dimesylate Capsules, Date of Enter into This Industry

2.8 Global Lisdexamfetamine Dimesylate Capsules Market Competitive Situation and Trends

2.8.1 Global Lisdexamfetamine Dimesylate Capsules Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Lisdexamfetamine Dimesylate Capsules Players Market Share by Revenue

2.8.3 Global Lisdexamfetamine Dimesylate Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Lisdexamfetamine Dimesylate Capsules Market Scenario by Region

3.1 Global Lisdexamfetamine Dimesylate Capsules Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2020-2031

3.2.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2020-2025

3.2.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Region: 2026-2031

3.3 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2020-2031

3.3.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2020-2025

3.3.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2026-2031

3.4 North America Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country

3.4.1 North America Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2031)

3.4.3 North America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country

3.5.1 Europe Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2031)

3.5.3 Europe Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Region

3.6.1 Asia Pacific Lisdexamfetamine Dimesylate Capsules Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Region (2020-2031)

3.6.3 Asia Pacific Lisdexamfetamine Dimesylate Capsules Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country

3.7.1 Latin America Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2031)

3.7.3 Latin America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.7.7 Colombia

3.8 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Facts & Figures by Country

3.8.1 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2031)

3.8.3 Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2020-2031)

4.1.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2020-2025)

4.1.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Type (2026-2031)

4.1.3 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2020-2031)

4.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2020-2031)

4.2.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2020-2025)

4.2.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Type (2026-2031)

4.2.3 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2020-2031)

4.3 Global Lisdexamfetamine Dimesylate Capsules Price by Type (2020-2031)

5 Segment by Application

5.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2020-2031)

5.1.1 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2020-2025)

5.1.2 Global Lisdexamfetamine Dimesylate Capsules Sales by Application (2026-2031)

5.1.3 Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2020-2031)

5.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2020-2031)

5.2.1 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2020-2025)

5.2.2 Global Lisdexamfetamine Dimesylate Capsules Revenue by Application (2026-2031)

5.2.3 Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2020-2031)

5.3 Global Lisdexamfetamine Dimesylate Capsules Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Takeda Pharmaceutical

6.1.1 Takeda Pharmaceutical Company Information

6.1.2 Takeda Pharmaceutical Description and Business Overview

6.1.3 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.1.5 Takeda Pharmaceutical Recent Developments/Updates

6.2 Hikma Pharmaceuticals

6.2.1 Hikma Pharmaceuticals Company Information

6.2.2 Hikma Pharmaceuticals Description and Business Overview

6.2.3 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.2.5 Hikma Pharmaceuticals Recent Developments/Updates

6.3 Amneal Pharmaceuticals

6.3.1 Amneal Pharmaceuticals Company Information

6.3.2 Amneal Pharmaceuticals Description and Business Overview

6.3.3 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.3.5 Amneal Pharmaceuticals Recent Developments/Updates

6.4 Sun Pharmaceutical

6.4.1 Sun Pharmaceutical Company Information

6.4.2 Sun Pharmaceutical Description and Business Overview

6.4.3 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.4.5 Sun Pharmaceutical Recent Developments/Updates

6.5 Teva Pharmaceutical

6.5.1 Teva Pharmaceutical Company Information

6.5.2 Teva Pharmaceutical Description and Business Overview

6.5.3 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.5.5 Teva Pharmaceutical Recent Developments/Updates

6.6 Mallinckrodt PLC

6.6.1 Mallinckrodt PLC Company Information

6.6.2 Mallinckrodt PLC Description and Business Overview

6.6.3 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.6.5 Mallinckrodt PLC Recent Developments/Updates

6.7 Mylan

6.7.1 Mylan Company Information

6.7.2 Mylan Description and Business Overview

6.7.3 Mylan Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Mylan Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.7.5 Mylan Recent Developments/Updates

6.8 Sandoz

6.8.1 Sandoz Company Information

6.8.2 Sandoz Description and Business Overview

6.8.3 Sandoz Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Sandoz Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.8.5 Sandoz Recent Developments/Updates

6.9 Ascent Pharmaceuticals

6.9.1 Ascent Pharmaceuticals Company Information

6.9.2 Ascent Pharmaceuticals Description and Business Overview

6.9.3 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.9.5 Ascent Pharmaceuticals Recent Developments/Updates

6.10 Alkem Laboratories

6.10.1 Alkem Laboratories Company Information

6.10.2 Alkem Laboratories Description and Business Overview

6.10.3 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.10.5 Alkem Laboratories Recent Developments/Updates

6.11 Apotex

6.11.1 Apotex Company Information

6.11.2 Apotex Description and Business Overview

6.11.3 Apotex Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Apotex Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.11.5 Apotex Recent Developments/Updates

6.12 Lannett

6.12.1 Lannett Company Information

6.12.2 Lannett Description and Business Overview

6.12.3 Lannett Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Lannett Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.12.5 Lannett Recent Developments/Updates

6.13 Zhejiang Huahai Pharmaceutical

6.13.1 Zhejiang Huahai Pharmaceutical Company Information

6.13.2 Zhejiang Huahai Pharmaceutical Description and Business Overview

6.13.3 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product Portfolio

6.13.5 Zhejiang Huahai Pharmaceutical Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Lisdexamfetamine Dimesylate Capsules Industry Chain Analysis

7.2 Lisdexamfetamine Dimesylate Capsules Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Lisdexamfetamine Dimesylate Capsules Production Mode & Process Analysis

7.4 Lisdexamfetamine Dimesylate Capsules Sales and Marketing

7.4.1 Lisdexamfetamine Dimesylate Capsules Sales Channels

7.4.2 Lisdexamfetamine Dimesylate Capsules Distributors

7.5 Lisdexamfetamine Dimesylate Capsules Customer Analysis

8 Lisdexamfetamine Dimesylate Capsules Market Dynamics

8.1 Lisdexamfetamine Dimesylate Capsules Industry Trends

8.2 Lisdexamfetamine Dimesylate Capsules Market Drivers

8.3 Lisdexamfetamine Dimesylate Capsules Market Challenges

8.4 Lisdexamfetamine Dimesylate Capsules Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Takeda Pharmaceutical

Hikma Pharmaceuticals

Amneal Pharmaceuticals

Ascent Pharmaceuticals

Alkem Laboratories

Apotex

Lannett

Zhejiang Huahai Pharmaceutical

List of Tables

Table 1. Global Lisdexamfetamine Dimesylate Capsules Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Lisdexamfetamine Dimesylate Capsules Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Lisdexamfetamine Dimesylate Capsules Market Competitive Situation by Manufacturers in 2024

Table 4. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Lisdexamfetamine Dimesylate Capsules Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Lisdexamfetamine Dimesylate Capsules Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Lisdexamfetamine Dimesylate Capsules Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Lisdexamfetamine Dimesylate Capsules, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Lisdexamfetamine Dimesylate Capsules, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Lisdexamfetamine Dimesylate Capsules, Product Type & Application

Table 12. Global Key Manufacturers of Lisdexamfetamine Dimesylate Capsules, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Lisdexamfetamine Dimesylate Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lisdexamfetamine Dimesylate Capsules as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Lisdexamfetamine Dimesylate Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2020-2025) & (K Units)

Table 18. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2020-2025)

Table 19. Global Lisdexamfetamine Dimesylate Capsules Sales by Region (2026-2031) & (K Units)

Table 20. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2026-2031)

Table 21. Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2020-2025)

Table 23. Global Lisdexamfetamine Dimesylate Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2026-2031)

Table 25. North America Lisdexamfetamine Dimesylate Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2025) & (K Units)

Table 27. North America Lisdexamfetamine Dimesylate Capsules Sales by Country (2026-2031) & (K Units)

Table 28. North America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2025) & (K Units)

Table 32. Europe Lisdexamfetamine Dimesylate Capsules Sales by Country (2026-2031) & (K Units)

Table 33. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Lisdexamfetamine Dimesylate Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Lisdexamfetamine Dimesylate Capsules Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Lisdexamfetamine Dimesylate Capsules Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Lisdexamfetamine Dimesylate Capsules Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Lisdexamfetamine Dimesylate Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Lisdexamfetamine Dimesylate Capsules Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Lisdexamfetamine Dimesylate Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units) by Type (2020-2025)

Table 51. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units) by Type (2026-2031)

Table 52. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2020-2025)

Table 53. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Type (2026-2031)

Table 54. Global Lisdexamfetamine Dimesylate Capsules Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Lisdexamfetamine Dimesylate Capsules Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2020-2025)

Table 57. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Type (2026-2031)

Table 58. Global Lisdexamfetamine Dimesylate Capsules Price (US$/Unit) by Type (2020-2025)

Table 59. Global Lisdexamfetamine Dimesylate Capsules Price (US$/Unit) by Type (2026-2031)

Table 60. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units) by Application (2020-2025)

Table 61. Global Lisdexamfetamine Dimesylate Capsules Sales (K Units) by Application (2026-2031)

Table 62. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2020-2025)

Table 63. Global Lisdexamfetamine Dimesylate Capsules Sales Market Share by Application (2026-2031)

Table 64. Global Lisdexamfetamine Dimesylate Capsules Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Lisdexamfetamine Dimesylate Capsules Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2020-2025)

Table 67. Global Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Application (2026-2031)

Table 68. Global Lisdexamfetamine Dimesylate Capsules Price (US$/Unit) by Application (2020-2025)

Table 69. Global Lisdexamfetamine Dimesylate Capsules Price (US$/Unit) by Application (2026-2031)

Table 70. Takeda Pharmaceutical Company Information

Table 71. Takeda Pharmaceutical Description and Business Overview

Table 72. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Takeda Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product

Table 74. Takeda Pharmaceutical Recent Developments/Updates

Table 75. Hikma Pharmaceuticals Company Information

Table 76. Hikma Pharmaceuticals Description and Business Overview

Table 77. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Hikma Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product

Table 79. Hikma Pharmaceuticals Recent Developments/Updates

Table 80. Amneal Pharmaceuticals Company Information

Table 81. Amneal Pharmaceuticals Description and Business Overview

Table 82. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Amneal Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product

Table 84. Amneal Pharmaceuticals Recent Developments/Updates

Table 85. Sun Pharmaceutical Company Information

Table 86. Sun Pharmaceutical Description and Business Overview

Table 87. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Sun Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product

Table 89. Sun Pharmaceutical Recent Developments/Updates

Table 90. Teva Pharmaceutical Company Information

Table 91. Teva Pharmaceutical Description and Business Overview

Table 92. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. Teva Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product

Table 94. Teva Pharmaceutical Recent Developments/Updates

Table 95. Mallinckrodt PLC Company Information

Table 96. Mallinckrodt PLC Description and Business Overview

Table 97. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Mallinckrodt PLC Lisdexamfetamine Dimesylate Capsules Product

Table 99. Mallinckrodt PLC Recent Developments/Updates

Table 100. Mylan Company Information

Table 101. Mylan Description and Business Overview

Table 102. Mylan Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Mylan Lisdexamfetamine Dimesylate Capsules Product

Table 104. Mylan Recent Developments/Updates

Table 105. Sandoz Company Information

Table 106. Sandoz Description and Business Overview

Table 107. Sandoz Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Sandoz Lisdexamfetamine Dimesylate Capsules Product

Table 109. Sandoz Recent Developments/Updates

Table 110. Ascent Pharmaceuticals Company Information

Table 111. Ascent Pharmaceuticals Description and Business Overview

Table 112. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Ascent Pharmaceuticals Lisdexamfetamine Dimesylate Capsules Product

Table 114. Ascent Pharmaceuticals Recent Developments/Updates

Table 115. Alkem Laboratories Company Information

Table 116. Alkem Laboratories Description and Business Overview

Table 117. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. Alkem Laboratories Lisdexamfetamine Dimesylate Capsules Product

Table 119. Alkem Laboratories Recent Developments/Updates

Table 120. Apotex Company Information

Table 121. Apotex Description and Business Overview

Table 122. Apotex Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. Apotex Lisdexamfetamine Dimesylate Capsules Product

Table 124. Apotex Recent Developments/Updates

Table 125. Lannett Company Information

Table 126. Lannett Description and Business Overview

Table 127. Lannett Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Lannett Lisdexamfetamine Dimesylate Capsules Product

Table 129. Lannett Recent Developments/Updates

Table 130. Zhejiang Huahai Pharmaceutical Company Information

Table 131. Zhejiang Huahai Pharmaceutical Description and Business Overview

Table 132. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Zhejiang Huahai Pharmaceutical Lisdexamfetamine Dimesylate Capsules Product

Table 134. Zhejiang Huahai Pharmaceutical Recent Developments/Updates

Table 135. Key Raw Materials Lists

Table 136. Raw Materials Key Suppliers Lists

Table 137. Lisdexamfetamine Dimesylate Capsules Distributors List

Table 138. Lisdexamfetamine Dimesylate Capsules Customers List

Table 139. Lisdexamfetamine Dimesylate Capsules Market Trends

Table 140. Lisdexamfetamine Dimesylate Capsules Market Drivers

Table 141. Lisdexamfetamine Dimesylate Capsules Market Challenges

Table 142. Lisdexamfetamine Dimesylate Capsules Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

Table 146. Authors List of This Report

List of Figures

Figure 1. Product Picture of Lisdexamfetamine Dimesylate Capsules

Figure 2. Global Lisdexamfetamine Dimesylate Capsules Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Lisdexamfetamine Dimesylate Capsules Market Share by Type: 2024 & 2031

Figure 4. 10mg per Unit Product Picture

Figure 5. 20mg per Unit Product Picture

Figure 6. 30mg per Unit Product Picture

Figure 7. 40mg per Unit Product Picture

Figure 8. 50mg per Unit Product Picture

Figure 9. 60mg per Unit Product Picture

Figure 10. 70mg per Unit Product Picture

Figure 11. Global Lisdexamfetamine Dimesylate Capsules Market Value by Application (2020-2031) & (US$ Million)

Figure 12. Global Lisdexamfetamine Dimesylate Capsules Market Share by Application: 2024 & 2031

Figure 13. Attention Deficit Hyperactivity Disorder(ADHD)

Figure 14. Bulimia

Figure 15. Other

Figure 16. Global Lisdexamfetamine Dimesylate Capsules Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Lisdexamfetamine Dimesylate Capsules Market Size (2020-2031) & (US$ Million)

Figure 18. Global Lisdexamfetamine Dimesylate Capsules Sales (2020-2031) & (K Units)

Figure 19. Global Lisdexamfetamine Dimesylate Capsules Average Price (US$/Unit) & (2020-2031)

Figure 20. Lisdexamfetamine Dimesylate Capsules Report Years Considered

Figure 21. Lisdexamfetamine Dimesylate Capsules Sales Share by Manufacturers in 2024

Figure 22. Global Lisdexamfetamine Dimesylate Capsules Revenue Share by Manufacturers in 2024

Figure 23. Global 5 and 10 Largest Lisdexamfetamine Dimesylate Capsules Players: Market Share by Revenue in Lisdexamfetamine Dimesylate Capsules in 2024

Figure 24. Lisdexamfetamine Dimesylate Capsules Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 25. Global Lisdexamfetamine Dimesylate Capsules Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 26. North America Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2020-2031)

Figure 27. North America Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Country (2020-2031)

Figure 28. United States Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. Canada Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Europe Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2020-2031)

Figure 31. Europe Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Country (2020-2031)

Figure 32. Germany Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. France Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. U.K. Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Italy Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. Russia Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. Asia Pacific Lisdexamfetamine Dimesylate Capsules Sales Market Share by Region (2020-2031)

Figure 38. Asia Pacific Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Region (2020-2031)

Figure 39. China Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Japan Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. South Korea Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. India Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Australia Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. China Taiwan Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Southeast Asia Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Latin America Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2020-2031)

Figure 47. Latin America Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Country (2020-2031)

Figure 48. Mexico Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Brazil Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Argentina Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Colombia Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Lisdexamfetamine Dimesylate Capsules Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. UAE Lisdexamfetamine Dimesylate Capsules Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Lisdexamfetamine Dimesylate Capsules by Type (2020-2031)

Figure 58. Global Revenue Market Share of Lisdexamfetamine Dimesylate Capsules by Type (2020-2031)

Figure 59. Global Lisdexamfetamine Dimesylate Capsules Price (US$/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Lisdexamfetamine Dimesylate Capsules by Application (2020-2031)

Figure 61. Global Revenue Market Share of Lisdexamfetamine Dimesylate Capsules by Application (2020-2031)

Figure 62. Global Lisdexamfetamine Dimesylate Capsules Price (US$/Unit) by Application (2020-2031)

Figure 63. Lisdexamfetamine Dimesylate Capsules Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions